1-20 of 25
Mark Juckett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ziftomenib in combination with venetoclax and azacitidine in relapsed/refractory NPM1-m or KMT2A-r acute myeloid leukemia: Updated phase 1a/b safety and clinical activity results from KOMET-007

Free
Ghayas Issa, Amir Fathi, Amer Zeidan, Harry Erba, Gail Roboz, Jessica Altman, Keith Pratz, Mark Juckett, Tara Lin, Suresh Kumar Balasubramanian, Anjali Advani, Gary Schiller, Neil Palmisiano, Marcello Rotta, Stephen Strickland, Christine McMahon, Yazan Madanat, Talha Badar, Mohamad Khawandanah, George Yaghmour, James McCloskey, James Mangan, Antoine Saliba, Ivana Gojo, Diaa Osman, Hongling Zhang, Ying Tian, Marcie Riches, Daniel Corum, Mollie Leoni, Eunice Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 764.
https://doi.org/10.1182/blood-2025-764
Published: 2025
Journal Articles

Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data

Free
Piyanuch Kongtim, Andrew Portuguese, Soyoung Kim, Andrew Peterson, Hany Elmariah, Lori Muffly, Mark Juckett, Michael Grunwald, Mariam Nawas, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Xia Bi, Ryan Stubbins, Wael Saber, Stefan Ciurea, Bart Scott
Journal: Blood
Blood (2025) 146 (Supplement 1): 109.
https://doi.org/10.1182/blood-2025-109
Published: 2025
Journal Articles

Risk of relapse and mortality after non-myeloablative allogeneic stem cell transplant for Acute Myeloid Leukemia and myelodysplastic syndrome after fludarabine, cyclophosphamide, and 200 centigray total body irradiation  with gvhd prophylaxis using post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil: Impact of maintenance chemotherapy

Free
Christopher Graham, Roy Kao, Qing Cao, Cameron McDonald-Hyman, Joseph Norton, Punita Grover, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 7781.
https://doi.org/10.1182/blood-2025-7781
Published: 2025
Journal Articles

Phase I/II clinical trial of bortezomib in combination with CPX-351 for the treatment of newly-diagnosed TP53-mutated Acute Myeloid Leukemia (NCT07008638)

Free
Joseph Norton, Nuttavut Sumransub, Kieth Cordner, Jeremy Allred, Naveen Premnath, Sean Tracy, Craig Eckfeldt, Qing Cao, Mark Juckett, Veronika Bachanova, Zohar Sachs
Journal: Blood
Blood (2025) 146 (Supplement 1): 3433.
https://doi.org/10.1182/blood-2025-3433
Published: 2025
Journal Articles

Allogeneic hematopoietic stem cell transplantation for hematological malignancies using nonmyeloablative fludarabine, cyclophosphamide, 200 centigray total body irradiation, and post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil for graft-versus-host disease prophylaxis is associated with low non-relapse mortality.

Free
Christopher Graham, Roy Kao, Qing Cao, Punita Grover, Joseph Norton, Cameron McDonald-Hyman, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 4220.
https://doi.org/10.1182/blood-2025-4220
Published: 2025
Journal Articles

Coronary artery calcification and its effect on cardiac events in patients undergoing allogeneic stem cell transplantation using nonmyeloablative conditioning

Free
Christopher Graham, Roy Kao, Qing Cao, Cameron McDonald-Hyman, Joseph Norton, Punita Grover, Joseph Maakaron, Jeremy Allred, Veronika Bachanova, Jeffrey Miller, Daniel Weisdorf, Mark Juckett
Journal: Blood
Blood (2025) 146 (Supplement 1): 4219.
https://doi.org/10.1182/blood-2025-4219
Published: 2025
Journal Articles

Upstream integration of implementation planning in clinical trials through the blood and marrow transplant clinical trials network

Free
Anna Desalvo, Brittany Ragon, Neel Bhatt, Betty K. Hamilton, Azra Borogovac, Mary Horowitz, Nandita Khera, Mark Juckett, Steven Devine, Christopher Dandoy, Alla Keyzner, Yvonne Efebera, John Plastaras, Mitchell Horwitz, Sarah Wall, Valerie Stewart, Mykala Heuer, Todd Molfenter
Journal: Blood
Blood (2025) 146 (Supplement 1): 7913.
https://doi.org/10.1182/blood-2025-7913
Published: 2025
Journal Articles

Real-world outcomes with blinatumomab as a bridging therapy for allogeneic hematopoietic stem cell transplantation in relapsed/refractory or measurable residual disease-positive B-cell acute lymphoblastic leukemia: A CIBMTR database analysis

Free
Wael Saber, Ruta Brazauskas, Jinalben Patel, Mona Patel, Lori Muffly, Mark Juckett, Michael Grunwald, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Heejoo Jo, Biyao Zou, Jessica Choudhry, Yi Zeng
Journal: Blood
Blood (2025) 146 (Supplement 1): 6044.
https://doi.org/10.1182/blood-2025-6044
Published: 2025
Journal Articles

Gtb-3650 (anti-CD16/IL-15/anti-CD33) tri-specific killer engager (TriKE®) for the treatment of high risk myelodysplastic syndromes (MDS) and refractory/relapsed (R/R) Acute Myeloid Leukemia (AML) (NCT06594445)

Free
Mark Juckett, Christopher Graham, Punita Grover, Joseph Norton, Naveen Premnath, Craig Eckfeldt, Zohar Sachs, Cassie Seichter, Andrea Hoeschen, Cameron McDonald-Hyman, Jeremy Allred, Rose Wangen, Martin Felices, Jeffrey Miller
Journal: Blood
Blood (2025) 146 (Supplement 1): 6947.
https://doi.org/10.1182/blood-2025-6947
Published: 2025
Journal Articles

Phase I Study of FT538 + Daratumumab for Treatment of r/r AML

Free
Joseph E. Maakaron, Cassie Seichter, Rose Wangen, Andrea Hoeschen, Deepa Kolaseri Krishnadas, Kateryna Kent, Ryan Shanley, Daniel O'Leary, Najla H El Jurdi, Shernan G. Holtan, Brian Betts, Mark Juckett, Jeffrey S Miller
Journal: Blood
Blood (2023) 142 (Supplement 1): 4842.
https://doi.org/10.1182/blood-2023-189132
Published: 2023
Journal Articles

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus

Free
Shernan G. Holtan, Kelly Walton, Najla H El Jurdi, Joseph E. Maakaron, Mark Juckett, Veronika Bachanova, Thomas Myers, Linda J. Paradiso, Todd DeFor, Qing Cao, Brian Betts
Journal: Blood
Blood (2023) 142 (Supplement 1): 4925.
https://doi.org/10.1182/blood-2023-181292
Published: 2023
Journal Articles

Simvastatin with Intrathecal Dexamethasone Reduces Neurotoxicity in Adults Receiving Chimeric Antigen Receptor (CAR) T-Cells Treatment

Free
Nuttavut Sumransub, Cassie Seichter, Kateryna Kent, Ryan Shanley, Marie Hu, Daniel O'Leary, Najla H El Jurdi, Shernan G. Holtan, Brian Betts, Mark Juckett, Jeremy R. Allred, Veronika Bachanova, Jeffrey S Miller, Joseph E. Maakaron
Journal: Blood
Blood (2023) 142 (Supplement 1): 3493.
https://doi.org/10.1182/blood-2023-187070
Published: 2023
Journal Articles

Impact of Publicly Reported Center Specific Analysis on Patient Selection Practices for Hematopoietic Stem Cell Transplantation

Free
Christopher Strouse, Mark Juckett, Brent R. Logan, Noel Estrada-Merly, Jaime M. Preussler, Tony Truong, Jesse Troy, Nandita Khera, William Wood, Hemalatha G. Rangarajan, Luke Akard, Neel S. Bhatt, Akshay Sharma, Wael Saber
Journal: Blood
Blood (2023) 142 (Supplement 1): 373.
https://doi.org/10.1182/blood-2023-182013
Published: 2023
Journal Articles

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in Gvhd Risk without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

Free
Alex Hoover, Daniel O'Leary, Qing Cao, Ashish O. Gupta, Christen L. Ebens, Joseph E. Maakaron, Brian C. Betts, Mark Juckett, Troy C. Lund, Veronika Bachanova, Margaret L. MacMillan, Jeffrey S. Miller, MD, Paul J. Orchard, John E Wagner, Gregory M. Vercellotti, Daniel J. Weisdorf, Kathryn Dusenbery, Stephanie Terezakis, Shernan G Holtan, Najla H El Jurdi
Journal: Blood
Blood (2022) 140 (Supplement 1): 282–283.
https://doi.org/10.1182/blood-2022-165782
Published: 2022
Journal Articles

A Phase I Study of FT538, an Off-the-Shelf, Multiplexed-Engineered, iPSC-Derived NK Cell Therapy in Combination with Daratumumab in Relapsed/Refractory Multiple Myeloma

Free
Mark Juckett, Sham Mailankody, Alireza Eghtedar, Cara Bickers, Xingyue Zong, Lilly Wong, Thomas Ly, John Byon, Sarah Cooley, Bahram Valamehr, Yu-Waye Chu, Ravi Vij
Journal: Blood
Blood (2022) 140 (Supplement 1): 10327–10328.
https://doi.org/10.1182/blood-2022-166728
Published: 2022
Journal Articles

A Novel Dual-Antigen Targeting Approach Enables Off-the-Shelf CAR NK Cells to Effectively Recognize and Eliminate the Heterogenous Population Associated with AML

Free
Zachary Davis, Frank Cichocki, Martin Felices, Hongbo Wang, Peter Hinderlie, Mark Juckett, Joseph Maakaron, Gregory I. Berk, Bryan Hancock, John Goulding, Ryan Bjordahl, Bahram Valamehr, Jeffrey S. Miller, MD
Journal: Blood
Blood (2022) 140 (Supplement 1): 10288–10289.
https://doi.org/10.1182/blood-2022-168981
Published: 2022
Journal Articles

Mgta-117, an Anti-CD117 Antibody-Drug Conjugated with Amanitin, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics and Pharmacodynamics Initial Findings from a Phase 1/2 Study

Free
Peter Westervelt, Partow Kebriaei, Mark Juckett, Andrew S. Artz, Onyee Chan, Philip L. McCarthy, Sherif S Farag, Anurag K. Singh, Eytan Stein, Jeffrey Humphrey, William Baeder, Ji Hyun Lee, Alison Occhiuti, Jeanie Tang, David Santos, Kirk Bertelsen, Balaji Mahender, Nicole Henry, Shawn Rose
Journal: Blood
Blood (2022) 140 (Supplement 1): 2117–2119.
https://doi.org/10.1182/blood-2022-162406
Published: 2022
Journal Articles

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Free
Clinical Trials & Observations
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai-Ho, Rohtesh Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John Galvin, Annie Im, Amelia Langston, Jane Liesveld, Mark Juckett, Aaron Logan, Levanto Schachter, Asif Alavi, Dianna Howard, Harlan W. Waksal, John Ryan, David Eiznhamer, Sanjay K. Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Pavletic
Journal: Blood
Blood (2021) 138 (22): 2278–2289.
https://doi.org/10.1182/blood.2021012021
Published: 2021
Includes: Supplemental data
Journal Articles

Icans Prophylaxis with Simvastatin and Intrathecal Dexamethasone in Adults Receiving Axicabtagene Ciloleucel (Axi‐Cel) Treatment

Free
Joseph Maakaron, Emily Stene, Megan Bruns, Todd E. DeFor, Najla H El Jurdi, Veronika Bachanova, Daniel J. Weisdorf, Jeffrey S. Miller, Murali Janakiram, Mark Juckett
Journal: Blood
Blood (2021) 138 (Supplement 1): 1744.
https://doi.org/10.1182/blood-2021-149607
Published: 2021
Journal Articles

Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

Free
Muhammad Umair Mushtaq, MD, Sibgha Gull Chaudhary, MD, Laura C. Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Sameem Abedin, MD, Lyndsey Runass, MD, Michael J. Fallon, PharmD, Alexandra M. Harrington, MD, Mark Juckett, MD, Aric C. Hall, MD, Ryan J. Mattison, MD, Ehab L. Atallah, MD, Guru Subramanian Guru Murthy, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2708.
https://doi.org/10.1182/blood-2018-99-113764
Published: 2018